Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1982 3
2008 2
2009 1
2011 1
2013 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Telmisartan, ramipril, or both in patients at high risk for vascular events.
ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. ONTARGET Investigators, et al. N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31. N Engl J Med. 2008. PMID: 18378520 Free article. Clinical Trial.
[Hamman's sign (pneumomediastinum - pneumopericardium)].
Bladt D, Bekaert I, Van Durme JP. Bladt D, et al. Among authors: bekaert i. Acta Clin Belg. 1981;36(1):5-11. doi: 10.1080/22953337.1981.11718776. Acta Clin Belg. 1981. PMID: 7293640 Dutch. No abstract available.
Telmisartan and amlodipine single-pill combinations vs amlodipine monotherapy for superior blood pressure lowering and improved tolerability in patients with uncontrolled hypertension: results of the TEAMSTA-5 study.
Neldam S, Lang M, Jones R; TEAMSTA-5 Investigators. Neldam S, et al. J Clin Hypertens (Greenwich). 2011 Jul;13(7):459-66. doi: 10.1111/j.1751-7176.2011.00468.x. Epub 2011 Apr 22. J Clin Hypertens (Greenwich). 2011. PMID: 21762357 Free PMC article. Clinical Trial.
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators; Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P. Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, et al. Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Lancet. 2008. PMID: 18757085 Clinical Trial.
Efficacy and safety of coadministration of fenofibrate and ezetimibe compared with each as monotherapy in patients with type IIb dyslipidemia and features of the metabolic syndrome: a prospective, randomized, double-blind, three-parallel arm, multicenter, comparative study.
Ansquer JC, Bekaert I, Guy M, Hanefeld M, Simon A; Study Investigators. Ansquer JC, et al. Among authors: bekaert i. Am J Cardiovasc Drugs. 2009;9(2):91-101. doi: 10.1007/BF03256580. Am J Cardiovasc Drugs. 2009. PMID: 19331437 Clinical Trial.